TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23964468

Group type: EXPERIMENTAL
Intervention: Naturopathic treatment
Number of subjects: 348

Group type: COMPARATOR
Intervention: Orthopaedic treatment
Number of subjects: 348
Study: 19583076

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% (3 mg/kg) + Nitroglycerin (200 microg)
Number of subjects: 46
Study: 17241505

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 microg kg(‐1) bolus 10 min before induction plus 0.5 microg kg(‐1) h(‐1) infusions during maintenance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16108154

Group type: EXPERIMENTAL
Intervention: Induced sputum analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study: 11699169

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.2 mg/kg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Oral chloral hydrate (62.5 mg/kg) with promethazine (12.5 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Physiologic parameters (heart rate, blood pressure, respiratory rate, oxygen saturation)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Behavior assessments (crying, movement, sleep) using the Houpt Sedation Rating Scale
Number of subjects: 31

Group type: COMPARATOR
Intervention: Modified Vancouver Recovery Scale
Number of subjects: 31
Study: 9224438

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneous bolus)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sodium valproate (800 mg orally)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: L‐Dopa (500 mg orally)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GH‐releasing hormone (GH‐RH 1 microgram/kg body weight i.v. bolus)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8118565

Group type: EXPERIMENTAL
Intervention: Cefaclor (500 mg) twice daily for 10 days
Number of subjects: 108

Group type: COMPARATOR
Intervention: Amoxicillin (500 mg) three times daily for 10 days
Number of subjects: 108
Study: 3729164

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg twice daily for 3 days)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 30157946

Group type: EXPERIMENTAL
Intervention: Vitamin D, 4000 IE/day
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 27351099

Group type: EXPERIMENTAL
Intervention: Sedentary behavior intervention (minimized steps to ≤5000 steps/day for one week)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (continued normal physical activity levels)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sedentary behavior intervention (post-intervention resumption of normal physical activity for one week)
Number of subjects: 39
Study: 25120324

Group type: EXPERIMENTAL
Intervention: Early prophylactic (EP) pulmonary surfactant therapy
Number of subjects: 2540

Group type: COMPARATOR
Intervention: Late selective (LS) pulmonary surfactant therapy
Number of subjects: 2540
Study: 22171732

Group type: EXPERIMENTAL
Intervention: Computer-based brief multiple-health behavior intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control program (computer-based)
Number of subjects: 200
Study: 20354760

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study: 18552688

Group type: EXPERIMENTAL
Intervention: Pyridoxalated hemoglobin polyoxyethylene (PHP) at 0.25 mL/kg/hr (20 mg/kg/hr)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Pyridoxalated hemoglobin polyoxyethylene (PHP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 15780531

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - continuous combined 0.625 mg conjugated equine estrogen plus 2.5 mg/d medoxyprogesterone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Tibolone (T)
Number of subjects: 16

Group type: COMPARATOR
Intervention: DHEAS
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 16
Study: 12413000

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) - 2 sessions of 10 minutes of training at 30% of PImax, daily for 4 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Respiratory Muscle Stretch Gymnastics (RMSG) - 3 sessions of 5 RMSG patterns 4 times each, daily for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of RMSG and IMT
Number of subjects: 12
Study: 10530772

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg orally, twice daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 7839300

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy
Number of subjects: 0
Study: 1746970

Group type: EXPERIMENTAL
Intervention: HCFU administration (300-600 mg/day x 12 weeks or more)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Radical therapy only (Control Group A)
Number of subjects: 191
Study: 6180562

Group type: EXPERIMENTAL
Intervention: Flecainide (400 mg daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propafenone (900 mg daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mexiletine (600 mg daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30566416

Group type: EXPERIMENTAL
Intervention: L-Methylfolate (15 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 28892431

Group type: EXPERIMENTAL
Intervention: Nintedanib plus pemetrexed and cisplatin
Number of subjects: 87

Group type: COMPARATOR
Intervention: Nintedanib
Number of subjects: 87
Study: 26197360

Group type: EXPERIMENTAL
Intervention: Negative spoken words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Taboo spoken words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First block of trials with emotional words
Number of subjects: 0
Study: 24473908

Group type: EXPERIMENTAL
Intervention: Confocal laser endomicroscopy (CLE) with targeted biopsies
Number of subjects: 168

Group type: COMPARATOR
Intervention: White light endoscopy (WLE) with standard biopsy protocol
Number of subjects: 168
Study: 21761215

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 19442311

Group type: EXPERIMENTAL
Intervention: Midline incision with continuous fascial closure using slowly absorbable sutures (n=47, 55%) and braided sutures (n=32, 38%) with strength of 1 (n=48, 57%).
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Transverse incision with continuous fascial closure using slowly absorbable sutures (n=22, 41%) and braided sutures (n=27, 50%) with strength of 1 (n=30, 56%).
Number of subjects: 157
Study: 15202624

Group type: EXPERIMENTAL
Intervention: Home cooking group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Clinic cooking group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 44
Study: 11316402

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 4 mg
Number of subjects: 100
Study: 9666879

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg orally once daily for 12 months)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ketoconazole (200-600 mg orally daily)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ketoconazole alone
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Alendronate and ketoconazole
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 39
Study: 7978133

Group type: EXPERIMENTAL
Intervention: Plasmalyte 148
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 30
Study: 31325468

Group type: EXPERIMENTAL
Intervention: Generic direct-acting antivirals (DAAs) with sofosbuvir + ledipasvir ± ribavirin or sofosbuvir + daclatasvir ± ribavirin
Number of subjects: 48088

Group type: EXPERIMENTAL
Intervention: Generic direct-acting antivirals (DAAs)
Number of subjects: 48088
Study: 27672000

Group type: EXPERIMENTAL
Intervention: Robot-PLIF
Number of subjects: 78

Group type: COMPARATOR
Intervention: Freehand-PLIF
Number of subjects: 78
Study: 25952121

Group type: EXPERIMENTAL
Intervention: Combined manual acupuncture and massage therapy (MAMT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Manual acupuncture therapy (MAT)
Number of subjects: 96
Study: 24364801

Group type: EXPERIMENTAL
Intervention: Behavioral activation (BA) treatment for depression
Number of subjects: 23
Study: 21515198

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy plus either switch to another selective serotonin reuptake inhibitor (SSRI) or switch to venlafaxine
Number of subjects: 190

Group type: COMPARATOR
Intervention: Switch to another selective serotonin reuptake inhibitor (SSRI)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Switch to venlafaxine
Number of subjects: 190
Study: 18638603

Group type: EXPERIMENTAL
Intervention: Echocardiographic assessment using tissue Doppler imaging
Number of subjects: 74

Group type: COMPARATOR
Intervention: Echocardiographic assessment using pulse-wave Doppler
Number of subjects: 74
Study: 16522426

Group type: EXPERIMENTAL
Intervention: Repeat corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single course corticosteroids
Number of subjects: 0
Study: 14579884

Group type: EXPERIMENTAL
Intervention: Arabesk and Solobond
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Z 100 and Scotchbond 1
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Prodigy and OptiBond
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: FHC Merz light and Resulcin Aqua Prime/Monobond
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sculpt‐It and Bond 1
Number of subjects: 36

Group type: COMPARATOR
Intervention: Amelogen Universal with Permaquick (control)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Enamel versus human enamel (control for wear rates)
Number of subjects: 36
Study: 11049707

Group type: EXPERIMENTAL
Intervention: Single high dose gentamicin (4.5 mg/kg) plus metronidazole (500 mg) preoperatively
Number of subjects: 146

Group type: COMPARATOR
Intervention: Multiple standard dose gentamicin (1.5 mg/kg) plus metronidazole (500 mg) preoperatively and every 8h for 24h postoperatively
Number of subjects: 146
Study: 8776678

Group type: EXPERIMENTAL
Intervention: 0.72 g/kg (0.9 ml/kg) of ethanol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (family history negative controls matched on demography and substance use histories)
Number of subjects: 40
Study: 1458013

Group type: EXPERIMENTAL
Intervention: GH alone
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combination of GH plus oxandrolone
Number of subjects: 70

Group type: COMPARATOR
Intervention: GH alone and combination therapy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: GH therapy
Number of subjects: 70
Study: 3881209

Group type: EXPERIMENTAL
Intervention: Naloxone (10 micrograms/kg bolus followed by 5 micrograms h‐1 kg‐1 infusion)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline (corresponding volume bolus followed by saline infusion)
Number of subjects: 9
Study: 31101977

Group type: EXPERIMENTAL
Intervention: Multinutrient supplementation (omega‐3 fatty acids, folic acid, selenium, vitamin E, catechin, glycyrrhizin, and co‐enzyme Q10) for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (two unlabeled soft capsules containing 200 μg folic acid each, for 3 months)
Number of subjects: 60
Study: 28492084

Group type: EXPERIMENTAL
Intervention: NT-proBNP measurement
Number of subjects: 711

Group type: COMPARATOR
Intervention: Routine work-up
Number of subjects: 711
Study: 27082551

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 4299

Group type: COMPARATOR
Intervention: Baseline heart rate (highest vs lowest quartile)
Number of subjects: 4299

Group type: COMPARATOR
Intervention: Last assessment heart rate
Number of subjects: 4299

Group type: COMPARATOR
Intervention: Mean heart rate
Number of subjects: 4299

Group type: COMPARATOR
Intervention: Baseline heart rate adjusted for mean systolic blood pressure
Number of subjects: 4299

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 4299
Study: 24909468

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg and Metoclopramide 10 mg (DM group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Metoclopramide 10 mg (MO group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg (DO group)
Number of subjects: 90
Study: 22286528

Group type: EXPERIMENTAL
Intervention: Low-fat high-protein diet (30% protein, 40% carbohydrate, 30% fat)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Low-fat high-carbohydrate diet (15% protein, 55% carbohydrate, 30% fat)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Both groups (low-fat high-protein and low-fat high-carbohydrate)
Number of subjects: 419
Study: 20157135

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d
Number of subjects: 16608
Study: 17343543

Group type: EXPERIMENTAL
Intervention: Oral misoprostol, 50 microg every 4 h for up to three doses
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 15525998

Group type: EXPERIMENTAL
Intervention: Modafinil (400 mg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 11986955

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) treatment
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (without CsA)
Number of subjects: 38
Study: 9673558

Group type: EXPERIMENTAL
Intervention: CD44 variant 6 positive
Number of subjects: 98

Group type: COMPARATOR
Intervention: CD44 variant 6 negative and lymphatic invasion negative
Number of subjects: 98
Study: 8087629

Group type: EXPERIMENTAL
Intervention: HME filters (Hygrobaby DAR)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional humidifiers (Bennett Cascade Humidifier)
Number of subjects: 28
Study: 2667758

Group type: EXPERIMENTAL
Intervention: metoprolol 100 mg bid for 2 days
Number of subjects: 9
Study: 335924

Group type: EXPERIMENTAL
Intervention: Albuterol (170 micrograms)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoproterenol (150 micrograms)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30654643

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152

Group type: COMPARATOR
Intervention: Olanzapine and Placebo
Number of subjects: 152
Study: 27077785

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation and amniotic membrane graft (AMG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amniotic membrane graft (AMG) with tissue debridement
Number of subjects: 40
Study: 25487027

Group type: EXPERIMENTAL
Intervention: Preservative-free sodium hyaluronate 0.1% and preservative-free fluorometholone 0.1% eyedrops, 4 times a day in the first month and twice a day in the second month.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops, 4 times a day in the first month and twice a day in the second month.
Number of subjects: 80
Study: 24070809

Group type: EXPERIMENTAL
Intervention: VEGF inhibition (anti-VEGF therapy)
Number of subjects: 509
Study: 21651869

Group type: EXPERIMENTAL
Intervention: Propofol total intravenous anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sevoflurane inhalation anesthesia
Number of subjects: 90
Study: 18728936

Group type: EXPERIMENTAL
Intervention: Rehabilitation programme in a Mediterranean climate
Number of subjects: 124

Group type: COMPARATOR
Intervention: Rehabilitation programme in a Norwegian climate
Number of subjects: 124
Study: 16772718

Group type: EXPERIMENTAL
Intervention: TOTO regimen (4 years alternating treatment and observation, n = 30)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: TTOO regimen (2 years treatment followed by 2 years observation, n = 28)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Both groups (TOTO and TTOO)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: TOTO regimen
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: TTOO regimen
Number of subjects: 58
Study: 15115951

Group type: EXPERIMENTAL
Intervention: Galantamine hydrobromide
Number of subjects: 2600
Study: 11198661

Group type: EXPERIMENTAL
Intervention: i.m. vaccine
Number of subjects: 296

Group type: COMPARATOR
Intervention: i.m. placebo
Number of subjects: 296
Study: 9056064

Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline (375 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study: 8116453

Group type: EXPERIMENTAL
Intervention: Oral dose of 100 mg of bisaramil
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous dose of 35 mg of bisaramil
Number of subjects: 6
Study: 3086575

Group type: COMPARATOR
Intervention: Mitomycin C (40 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thiotepa (60 mg)
Number of subjects: 40
Study: 30250134

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Diet + Aerobic Training (Diet + AT)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Diet + Resistance Training (Diet + RT)
Number of subjects: 122
Study: 29360529

Group type: EXPERIMENTAL
Intervention: Aquablation
Number of subjects: 181

Group type: COMPARATOR
Intervention: Transurethral prostate resection
Number of subjects: 181
Study: 26014280

Group type: EXPERIMENTAL
Intervention: Support for confrontation when sexism is perceived as rare
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Support for confrontation when sexism is perceived as pervasive
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Personal self-affirmation manipulation
Number of subjects: 552
Study: 22180582

Group type: EXPERIMENTAL
Intervention: Active nicotine (1.0 mcg/kg/min)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Alcohol (targeted breathalyzer of 40 mg% and 80 mg%)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo nicotine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo (no alcohol)
Number of subjects: 3
Study: 19878041

Group type: EXPERIMENTAL
Intervention: Acidic agents (citrate buffer solution, pineapple juice, green mango juice)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 4% acetic acid at 80 degrees C
Number of subjects: 35

Group type: COMPARATOR
Intervention: Deionized water
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Acidic agents
Number of subjects: 35
Study: 17712585

Group type: EXPERIMENTAL
Intervention: 250 ml orange juice and 250 ml blackcurrant juice
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 15 mg vitamin E
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 250 ml orange juice and 250 ml blackcurrant juice and 15 mg vitamin E
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control/placebo (energy-equivalent sugar-containing beverage)
Number of subjects: 48
Study: 16228828

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 391

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 391
Study: 12171815

Group type: EXPERIMENTAL
Intervention: FIO2 of 0.35
Number of subjects: 13

Group type: COMPARATOR
Intervention: FIO2 of 0.21 (control)
Number of subjects: 13
Study: 10464824

Group type: EXPERIMENTAL
Intervention: Codeine phosphate 0.4 mg kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Codeine phosphate and midazolam sedation
Number of subjects: 0
Study: 8541826

Group type: EXPERIMENTAL
Intervention: Asthma Rehabilitation Group (ARG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 40
Study: 2702016

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg nocte) - Long-term treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg nocte) - Seasonal treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg nocte) - Multicenter trial
Number of subjects: 60
Study: 319922

Group type: EXPERIMENTAL
Intervention: guanethidine
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: bethanidine
Number of subjects: 108
Study: 30955307

Group type: EXPERIMENTAL
Intervention: CSVD group (199 patients)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: CSVD-VCI group (112 patients)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Declined LVEF
Number of subjects: 199

Group type: COMPARATOR
Intervention: Normal control group (NC group, 103 healthy elderly persons)
Number of subjects: 199
Study: 27483410

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) + etanercept (ETN) combination therapy
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) + sulfasalazine (SSZ) + hydroxychloroquine (HCQ) triple therapy
Number of subjects: 550
Study: 25893569

Group type: EXPERIMENTAL
Intervention: Contact force-guided procedure (Group B)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-contact force-guided procedure (Group A)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 70
Study: 23870712

Group type: EXPERIMENTAL
Intervention: Multimode Comprehensive Tailored Information Package (MCTIP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Normal care (Control)
Number of subjects: 103
Study: 21430116

Group type: EXPERIMENTAL
Intervention: Folic acid (800 μg daily for 3 years)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 819
Study: 19880456

Group type: EXPERIMENTAL
Intervention: Edinburgh Postnatal Depression Screening Scale
Number of subjects: 5169

Group type: EXPERIMENTAL
Intervention: Screening linked to treatment options via referral and follow-up
Number of subjects: 5169

Group type: EXPERIMENTAL
Intervention: Best-practice strategies for implementing screening
Number of subjects: 5169
Study: 17112853

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) after conversion from azathioprine (AZA)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: CNI elimination or minimization
Number of subjects: 169
Study: 14988972

Group type: EXPERIMENTAL
Intervention: Automatic electronic record preventive care reminder system
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 10